DVA vs. EW: DaVita vs. Edwards Lifesciences Stock Comparison
How do DaVita (DVA) and Edwards Lifesciences (EW) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DaVita (DVA) and Edwards Lifesciences (EW) both fall under the Health Care Equipment & Services industry group, but DVA is classified in Health Care Providers & Services while EW is classified in Health Care Equipment & Supplies.
| Profile Item | DVA | EW |
|---|---|---|
| Name | DaVita Inc. | Edwards Lifesciences Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 12.04 billion USD | 58.73 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | October 31, 1995 | March 27, 2000 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DVA | EW |
|---|---|---|
| Total Return (1Y) | 51.64% | 25.08% |
| Total Return (3Y, Annualized) | 30.54% | 17.28% |
| Total Return (5Y, Annualized) | 11.92% | -2.77% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DVA | EW |
|---|---|---|
| Volatility (1Y, Annualized) | 46.86% | 25.58% |
| Beta (5Y) | 0.85 | 0.78 |
| Max Drawdown (5Y) | -46.98% | -54.32% |
| Avg. Volume (3M) | 713.76K | 3.69M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DVA | EW |
|---|---|---|
| Sharpe Ratio (1Y) | 1.01 | 0.81 |
| Sortino Ratio (1Y) | 1.78 | 1.23 |
Profitability
ROE (TTM)
DaVita (DVA) at 96.79% clears its industry range for ROE, a sharper capital-efficiency signal than Edwards Lifesciences (EW) at 9.33%, which is closer to a typical peer reading.
DVA
Health Care Equipment & Services industry group
96.79%
- DVA
- 96.79%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Edwards Lifesciences (EW) at 15.30% retains a top-quartile share of revenue as profit, ahead of DaVita (DVA) at 6.49%, which keeps about the industry-typical share.
DVA
Health Care Equipment & Services industry group
6.49%
- Max
- 29.35%
- Q3
- 9.33%
- DVA
- 6.49%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both DaVita (DVA) at 15.46% and Edwards Lifesciences (EW) at 30.15% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
DVA
Health Care Equipment & Services industry group
15.46%
- Max
- 35.43%
- DVA
- 15.46%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DVA | EW |
|---|---|---|
| ROE (TTM) | 96.79% | 9.33% |
| ROA (TTM) | 7.59% | 8.77% |
| Net Margin (TTM) | 6.49% | 15.30% |
| Operating Margin (TTM) | 15.46% | 30.15% |
| Gross Margin (TTM) | 32.28% | 78.02% |
Growth
Revenue Growth
Both DaVita (DVA) at 6.46% and Edwards Lifesciences (EW) at 11.55% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
DaVita (DVA) at -8.29% is around its peer norm for EPS growth, while Edwards Lifesciences (EW) at -73.74% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | DVA | EW |
|---|---|---|
| Revenue Growth (YoY) | 6.46% | 11.55% |
| Revenue Growth (3Y CAGR) | 5.53% | 10.77% |
| EPS Growth (YoY) | -8.29% | -73.74% |
| EPS Growth (3Y CAGR) | 18.93% | -9.14% |
Financial Strength
Current Ratio (MRQ)
DaVita (DVA) at 1.41 keeps current ratio within its industry’s typical mid-range, while Edwards Lifesciences (EW) at 4.60 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
DVA
Health Care Equipment & Services industry group
1.41
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DVA
- 1.41
- Q1
- 1.37
- Min
- 0.30
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower quartile, while DaVita (DVA) at 11.90 is above its industry debt-to-equity ratio range.
DVA
Health Care Equipment & Services industry group
11.90
- DVA
- 11.90
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
Financial Strength Metrics
| Metric | DVA | EW |
|---|---|---|
| Current Ratio (MRQ) | 1.41 | 4.60 |
| Debt / Equity (MRQ) | 11.90 | 0.06 |
| Net Debt / EBITDA | 4.51 | -1.88 |
Dividends
Dividend Yield (TTM)
Neither DaVita (DVA) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DVA
Health Care Equipment & Services industry group
0.00%
- DVA
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither DaVita (DVA) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DVA
Health Care Equipment & Services industry group
0.00%
- DVA
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DVA | EW |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
DaVita (DVA) at 14.49 sits in the cheaper P/E ratio quartile, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.
DVA
Health Care Equipment & Services industry group
14.49
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- DVA
- 14.49
- Min
- 4.21
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
DaVita (DVA) at 0.85 looks cheap on sales in the lower P/S ratio quartile, while Edwards Lifesciences (EW) at 8.80 looks rich in the upper quartile — a clear gap in price per dollar of revenue.
DVA
Health Care Equipment & Services industry group
0.85
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- DVA
- 0.85
- Min
- 0.03
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
DaVita (DVA) reports a negative P/B ratio of -20.52, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Edwards Lifesciences (EW) reports 5.41, ranking against industry peers normally.
DVA
Health Care Equipment & Services industry group
-20.52
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- DVA
- -20.52
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DVA | EW |
|---|---|---|
| P/E Ratio (TTM) | 14.49 | 59.38 |
| P/S Ratio (TTM) | 0.85 | 8.80 |
| P/B Ratio (MRQ) | -20.52 | 5.41 |
| Free Cash Flow Yield (TTM) | 7.52% | 1.95% |